Meva-C Capsule is a proprietary combination product containing Mebeverine hydrochloride (135mg) and Chlordiazepoxide (5mg) in a convenient capsule dosage form. Mebeverine, a musculotropic antispasmodic, effectively relieves smooth muscle spasms and cramps in the gastrointestinal tract, thereby providing relief from symptoms such as abdominal pain, bloating, and bowel irregularity. Chlordiazepoxide, a benzodiazepine derivative, exerts anxiolytic and sedative properties, which helps to reduce anxiety and stress, common concomitants of gastrointestinal disorders. The combination of these two agents in Meva-C Capsule provides a synergistic effect, allowing for the simultaneous treatment of gastrointestinal symptoms and anxiety-related disorders. The product is indicated for the relief of symptoms associated with irritable bowel syndrome (IBS), functional dyspepsia, and other gastrointestinal disorders characterized by abdominal pain, bloating, and bowel irregularity. Meva-C Capsule is available in a standardized strength and dosage regimen, and its administration is governed by the standard guidelines for the treatment of gastrointestinal disorders.